Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Softbank to Receive $7.59B Worth of T-Mobile Shares
Softbank to Receive $7.59B Worth of T-Mobile Shares
Workers' Strike Shuts down Eiffel Tower
Workers' Strike Shuts down Eiffel Tower
Amazon to Introduce Ads on Prime Video on Jan. 29
Amazon announced it would be bringing advertisements to its streaming service, Prime Video, at the end of January.
The New York Times Sues Microsoft and OpenAI
The New York Times has filed a lawsuit against Microsoft and Open AI, accusing both of infringing copyright and abusing the intellectual property of the newspaper.
Study: Why People Work During the Holidays
A new study is revealing how many people worked over the Christmas holiday.
Bristol Myers Squibb to Buy Cancer Drug Developer RayzeBio
Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Pizza Hut to Lay Off Over 1,200 Delivery Workers
Pizza Hut is set to lay off more than 1200 delivery workers in Los Angeles, Orange and Riverside counties in California.
Online Retailer Zulily Shuts Down
Online retailer Zulily said it's liquidating its assets and laying off hundreds of people.
New Drug May Help Children With Food Allergies
A new drug may provide relief to children against severe allergic reactions to peanut eggs, milk and other foods.
